Cytonus Therapeutics
Cytonus Therapeutics is pioneering the convergence of artificial intelligence and synthetic biology to revolutionize drug development and delivery. The company challenges the high failure rates of traditional and precision medicines by developing next-generation therapeutics that are both highly effective and safe. Their mission is to create pragmatic shifts in how drugs are designed and administered, focusing on precision, safety, and efficacy to improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
Products
Enucleated synthetic cell delivery platform
A synthetic biology delivery platform composed of pre-programmed, enucleated cell-like entities designed to home to diseased tissue after intravenous administration and locally produce biologic therapeutics.
Enucleated synthetic cell delivery platform
A synthetic biology delivery platform composed of pre-programmed, enucleated cell-like entities designed to home to diseased tissue after intravenous administration and locally produce biologic therapeutics.
Services
Application of AI models and workflows to generate, prioritize and screen therapeutic constructs for efficacy and safety.
Application of AI models and workflows to generate, prioritize and screen therapeutic constructs for efficacy and safety.
Expertise Areas
- AI-driven drug discovery
- Synthetic biology delivery platform development
- Targeted drug delivery
- In situ biologic production
Key Technologies
- Machine learning for therapeutic design
- Synthetic enucleated cell engineering
- Targeted drug-delivery platforms
- In situ biologic production
News & Updates
An article detailing the science and innovation behind Cytonus' targeted drug delivery platform, highlighting the transition from conceptual science to real-world application.
Cytonus has received funding from eight grants and support from industry-leading biotech investors, reflecting strong confidence in their innovative approach and technology.
An article detailing the science and innovation behind Cytonus' targeted drug delivery platform, highlighting the transition from conceptual science to real-world application.
Cytonus has received funding from eight grants and support from industry-leading biotech investors, reflecting strong confidence in their innovative approach and technology.